Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 20, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002664.pdf 0001562180-16-002664.rtf 0001562180-16-002664.xls View HTML
June 20, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002663.pdf 0001562180-16-002663.rtf 0001562180-16-002663.xls View HTML
June 20, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002661.pdf 0001562180-16-002661.rtf 0001562180-16-002661.xls View HTML
June 20, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002662.pdf 0001562180-16-002662.rtf 0001562180-16-002662.xls View HTML
June 20, 2016	4	Statement of changes in beneficial ownership of securities	0001562180-16-002666.pdf 0001562180-16-002666.rtf 0001562180-16-002666.xls View HTML
June 8, 2016	4/A	Amendment to a previously filed 4	0001562180-16-002559.pdf 0001562180-16-002559.rtf 0001562180-16-002559.xls View HTML
May 20, 2016	EFFECT	EFFECT	9999999995-16-004724.pdf 9999999995-16-004724.rtf 9999999995-16-004724.xls View HTML
May 18, 2016	CORRESP	CORRESP	0001193125-16-593872.pdf 0001193125-16-593872.rtf 0001193125-16-593872.xls View HTML
May 17, 2016	UPLOAD	UPLOAD	0000000000-16-076782.pdf View HTML
May 5, 2016	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-16-017968.pdf 0001564590-16-017968.rtf 0001564590-16-017968.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax